Suppressed cytokine production in whole blood cultures may be related to iron status and hepcidin and is partially corrected following weight reduction in morbidly obese pre-menopausal women

Cytokine

Volumn 53, Issue 2, 2011, Pages 201-206

  Tussing Humphreys, Lisa ^a   Pini, Maria ^b   Ponemone, Venkatesh ^b   Braunschweig, Carol ^b   Fantuzzi, Giamila ^b  

^a SOUTHERN REGIONAL RESEARCH CENTER   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Ex vivo LPS and ZY stimulated cytokine production; Hepcidin; Immunity; Iron status; Obesity

Indexed keywords

C REACTIVE PROTEIN; GAMMA INTERFERON; HEMOGLOBIN; HEPCIDIN; INTERLEUKIN 10; INTERLEUKIN 22; INTERLEUKIN 6; IRON; LIPOPOLYSACCHARIDE; TRANSFERRIN RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; ZYMOSAN;

ARTICLE; BARIATRIC SURGERY; BLOOD CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EX VIVO STUDY; FEMALE; HUMAN; INSULIN RESISTANCE; MORBID OBESITY; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; WEIGHT REDUCTION;

ANTHROPOMETRY; ANTIMICROBIAL CATIONIC PEPTIDES; BARIATRIC SURGERY; CELLS, CULTURED; CYTOKINES; FEMALE; HUMANS; INTERFERON-GAMMA; IRON; LINEAR MODELS; OBESITY, MORBID; PREMENOPAUSE; WEIGHT LOSS;

EID: 78651075834     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2010.11.008     Document Type: Article

References (43)

1. Karalis K.P., Giannogonas P., Kodela E., Koutmani Y., Zoumakis M., Teli T. Mechanisms of obesity and related pathology: linking immune responses to metabolic stress. FEBS J 2009, 276:5747-5754.
2. Goldberg R.B. Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications. J Clin Endocrinol Metab 2009, 94:3171-3182.
3. O'Shea D., Cawood T.J., O'Farrelly C., Lynch L. Natural killer cells in obesity: impaired function and increased susceptibility to the effects of cigarette smoke. PLoS One 2010, 5:e8660.
4. Zhou Q., Leeman S.E., Amar S. Signaling mechanisms involved in altered function of macrophages from diet-induced obese mice affect immune responses. Proc Natl Acad Sci USA 2009, 106:10740-10745.
5. Yang H., Youm Y.H., Vandanmagsar B., Rood J., Kumar K.G., Butler A.A., et al. Obesity accelerates thymic aging. Blood 2009, 114:3803-3812.
6. Pini M., Fantuzzi G. Enhanced production of IL-17A during zymosan-induced peritonitis in obese mice. J Leukoc Biol 2009, 87:51-58.
7. Nijhuis J., Rensen S.S., Slaats Y., van Dielen F.M., Buurman W.A., Greve J.W. Neutrophil activation in morbid obesity, chronic activation of acute inflammation. Obesity (Silver Spring) 2009, 17:2014-2018.
8. Winer S., Paltser G., Chan Y., Tsui H., Engleman E., Winer D., et al. Obesity predisposes to Th17 bias. Eur J Immunol 2009, 39:2629-2635.
9. Seligman P.A., Kovar J., Gelfand E.W. Lymphocyte proliferation is controlled by both iron availability and regulation of iron uptake pathways. Pathobiology 1992, 60:19-26.
10. Weiss G. Modification of iron regulation by the inflammatory response. Best Pract Res Clin Haematol 2005, 18:183-201.
11. Weiss G. Iron and immunity: a double-edged sword. Eur J Clin Invest 2002, 32(Suppl. 1):70-78.
12. Weiss G., Werner-Felmayer G., Werner E.R., Grunewald K., Wachter H., Hentze M.W. Iron regulates nitric oxide synthase activity by controlling nuclear transcription. J Exp Med 1994, 180:969-976.
13. Oppenheimer S.J. Iron and its relation to immunity and infectious disease. J Nutr 2001, 131:616S-633S. discussion 633S-5S.
14. Gordeuk V.R., Thuma P.E., Brittenham G.M., Zulu S., Simwanza G., Mhangu A., et al. Iron chelation with desferrioxamine B in adults with asymptomatic Plasmodium falciparum parasitemia. Blood 1992, 79:308-312.
15. Weiss G., Thuma P.E., Mabeza G., Werner E.R., Herold M., Gordeuk V.R. Modulatory potential of iron chelation therapy on nitric oxide formation in cerebral malaria. J Infect Dis 1997, 175:226-230.
16. Fritsche G., Larcher C., Schennach H., Weiss G. Regulatory interactions between iron and nitric oxide metabolism for immune defense against Plasmodium falciparum infection. J Infect Dis 2001, 183:1388-1394.
17. Joynson D.H., Walker D.M., Jacobs A., Dolby A.E. Defect of cell-mediated immunity in patients with iron-deficiency anaemia. Lancet 1972, 2:1058-1059.
18. Ahluwalia N., Sun J., Krause D., Mastro A., Handte G. Immune function is impaired in iron-deficient, homebound, older women. Am J Clin Nutr 2004, 79:516-521.
19. Yanoff L.B., Menzie C.M., Denkinger B., Sebring N.G., McHugh T., Remaley A.T., et al. Inflammation and iron deficiency in the hypoferremia of obesity. Int J Obes (Lond) 2007, 31:1412-1419.
20. Bekri S., Gual P., Anty R., Luciani N., Dahman M., Ramesh B., et al. Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH. Gastroenterology 2006, 131:788-796.
21. Tussing-Humphreys L.M., Nemeth E., Fantuzzi G., Freels S., Guzman G., Holterman A.X., et al. Elevated systemic hepcidin and iron depletion in obese premenopausal females. Obesity (Silver Spring) 2009, 18:1449-1456.
22. Ganz T. Hepcidin in iron metabolism. Curr Opin Hematol 2004, 11:251-254.
23. Nemeth E., Ganz T. Regulation of iron metabolism by hepcidin. Annu Rev Nutr 2006, 26:323-342.
24. Tussing-Humphreys L.M., Nemeth E., Fantuzzi G., Freels S., Holterman A.X., Galvani C., et al. Decreased serum hepcidin and improved functional iron status 6 months after restrictive bariatric surgery. Obesity (Silver Spring) 2010, 18:2020-2026.
25. Nguyen M.T., Favelyukis S., Nguyen A.K., Reichart D., Scott P.A., Jenn A., et al. A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Toll-like receptors 2 and 4 and JNK-dependent pathways. J Biol Chem 2007, 282:35279-35292.
26. Fain J.N. Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells. Vitam Horm 2006, 74:443-477.
27. Yang J., Li X., Hanidu A., Htut T.M., Sellati R., Wang L., et al. Proviral integration site 2 is required for interleukin-6 expression induced by interleukin-1, tumour necrosis factor-alpha and lipopolysaccharide. Immunology 2010, 131:174-182.
28. Strissel K.J., DeFuria J., Shaul M.E., Bennett G., Greenberg A.S., Obin M.S. T-cell recruitment and Th1 polarization in adipose tissue during diet-induced obesity in C57BL/6 mice. Obesity (Silver Spring) 2010, 18:1918-1925.
29. Pini M., Sennello J.A., Cabay R.J., Fantuzzi G. Effect of Diet-induced obesity on acute pancreatitis induced by administration of interleukin-12 plus interleukin-18 in mice. Obesity (Silver Spring) 2010, 18:476-482.
30. Block G., Woods M., Potosky A., Clifford C. Validation of a self-administered diet history questionnaire using multiple diet records. J Clin Epidemiol 1990, 43:1327-1335.
31. Ainsworth B.E., Sternfeld B., Richardson M.T., Jackson K. Evaluation of the kaiser physical activity survey in women. Med Sci Sports Exerc 2000, 32:1327-1338.
32. Lagrelius M., Jones P., Franck K., Gaines H. Cytokine detection by multiplex technology useful for assessing antigen specific cytokine profiles and kinetics in whole blood cultured up to seven days. Cytokine 2006, 33:156-165.
33. Ganz T., Olbina G., Girelli D., Nemeth E., Westerman M. Immunoassay for human serum hepcidin. Blood 2008, 112:4292-4297.
34. Karlsson E.A., Sheridan P.A., Beck M.A. Diet-induced obesity impairs the T cell memory response to influenza virus infection. J Immunol 2010, 184:3127-3133.
35. Miehsler W. Mortality, morbidity and special issues of obese ICU patients. Wien Med Wochenschr 2010, 160:124-128.
36. Zilverschoon G.R., Tack C.J., Joosten L.A., Kullberg B.J., van der Meer J.W., Netea M.G. Interleukin-18 resistance in patients with obesity and type 2 diabetes mellitus. Int J Obes (Lond) 2008, 32:1407-1414.
37. Fontana L., Eagon J.C., Colonna M., Klein S. Impaired mononuclear cell immune function in extreme obesity is corrected by weight loss. Rejuvenation Res 2007, 10:41-46.
38. Benson S., Janssen O.E., Hahn S., Tan S., Dietz T., Mann K., et al. Obesity, depression, and chronic low-grade inflammation in women with polycystic ovary syndrome. Brain Behav Immun 2008, 22:177-184.
39. Kueht M.L., McFarlin B.K., Lee R.E. Severely obese have greater LPS-stimulated TNF-alpha production than normal weight African-American women. Obesity (Silver Spring) 2009, 17:447-451.
40. Poniachik J., Csendes A., Diaz J.C., Rojas J., Burdiles P., Maluenda F., et al. Increased production of IL-1alpha and TNF-alpha in lipopolysaccharide-stimulated blood from obese patients with non-alcoholic fatty liver disease. Cytokine 2006, 33:252-257.
41. Colonna M. Interleukin-22-producing natural killer cells and lymphoid tissue inducer-like cells in mucosal immunity. Immunity 2009, 31:15-23.
42. Raymond N.C., Dysken M., Bettin K., Eckert E.D., Crow S.J., Markus K., et al. Cytokine production in patients with anorexia nervosa, bulimia nervosa, and obesity. Int J Eat Disord 2000, 28:293-302.
43. De Domenico I., Zhang T.Y., Koening C.L., Branch R.W., London N., Lo E., et al. Hepcidin mediates transcriptional changes that modulate acute cytokine-induced inflammatory responses in mice. J Clin Invest 2010, 120:2395-2405.